Skip to main content

Table 4 Studies of stereotactic body radiotherapy for stage I non-small cell lung cancer

From: Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancer

Author   Dose* median follow-up 3yLC 3yOS
(reference) n (Gy) (mo) (%) (%)
Onishi (2) 257 30-84(i) 38 NA 57
Timmerman (8) 55 54(p) 34 98 56
Nagata (10) 42 48(i) 30 NA 83 (T1 only)
Onimaru (21) 41 40-48(i) 27 57 47
Uematsu (30) 50 40-60(i) 60 NA 66
Koto (31) 31 45-60(i) 32 78 72
Nyman (32) 45 45(p) 43 80 55
Takeda (33) 38 50(p) 31 93 (T1 only) 90 (T1 only)
Taremi (34) 108 48-60(p) 19 89 (4y) 30 (4y)
Current study 109 48(i) or 40(p) 25 81 68
  1. *Dose was prescribed at the isocenter (i) or periphery (p) of the tumor.